4//SEC Filing
Hatten Sandra L 4
Accession 0001179110-19-012826
CIK 0001012477other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:21 PM ET
Size
6.6 KB
Accession
0001179110-19-012826
Insider Transaction Report
Form 4
Hatten Sandra L
See Remarks
Transactions
- Sale
ADSs
2019-12-12$7.23/sh−3,072$22,211→ 55,765 total
Holdings
- 3,400(indirect: By Spouse)
ADSs
Footnotes (3)
- [F1]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.20 to $7.56, inclusive. The reporting person undertakes to provide to Avadel Pharmaceuticals plc, any security holder of Avadel Pharmaceuticals plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
- [F3]The filing of this statement shall not be construed as an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of these securities. The reporting person disclaims beneficial ownership of such securities except to the extent of any pecuniary interest therein.
Documents
Issuer
AVADEL PHARMACEUTICALS PLC
CIK 0001012477
Entity typeother
Related Parties
1- filerCIK 0001600771
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 4:21 PM ET
- Size
- 6.6 KB